The REPERFUSE study protocol: The effects of vasopressor therapy on renal perfusion in patients with septic shock—A mechanistically focused randomised control trial
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304227 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Rory McDonald und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom. Hauptthemen laut MEDLINE: Acute Kidney Injury, Microcirculation, Shock, Septic, Vasoconstrictor Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Directorate, European Society of Intensive Care Medicine.
Themen: Sepsis
Abstract (Originalsprache)
Introduction
Acute kidney injury (AKI) is a common complication of septic shock and together these conditions carry a high mortality risk. In septic patients who develop severe AKI, renal cortical perfusion is deficient despite normal macrovascular organ blood flow. This intra-renal perfusion abnormality may be amenable to pharmacological manipulation, which may offer mechanistic insight into the pathophysiology of septic AKI. The aim of the current study is to investigate the effects of vasopressin and angiotensin II on renal microcirculatory perfusion in a cohort of patients with septic shock. Methods and analysis In this single centre, mechanistically focussed, randomised controlled study, 45 patients with septic shock will be randomly allocated to either of the study vasopressors (vasopressin or angiotensin II) or standard therapy (norepinephrine). Infusions will be titrated to maintain a mean arterial pressure (MAP) target set by the attending clinician. Renal microcirculatory assessment will be performed for the cortex and medulla using contrast-enhanced ultrasound (CEUS) and urinary oxygen tension (pO2), respectively. Renal macrovascular flow will be assessed via renal artery ultrasound. Measurement of systemic macrovascular flow will be performed through transthoracic echocardiography (TTE) and microvascular flow via sublingual incident dark field (IDF) video microscopy. Measures will be taken at baseline, +1 and +24hrs following infusion of the study drug commencing. Blood and urine samples will also be collected at the measurement time points. Longitudinal data will be compared between groups and over time.
Discussion
Vasopressors are integral to the management of patients with septic shock. This study aims to further understanding of the relationship between this therapy, renal perfusion and the development of AKI. In addition, using CEUS and urinary pO2, we hope to build a more complete picture of renal perfusion in septic shock by interrogation of the constituent parts of the kidney. Results will be published in peer-reviewed journals and presented at academic meetings.
Trial registration
The REPERFUSE study was registered on Clinical Trials.gov ( NCT06234592 ) on the 30 th Jan 24.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
- Academic Department of Anaesthesia and Critical Care, Royal Centre for Defence Medicine, Birmingham, United Kingdom.
- Department of Critical Care, King's College Hospital, London, United Kingdom.
- Pharmacy Department, King's College Hospital, London, United Kingdom.
- School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
- Department of Critical Care, Guy's & St Thomas' Hospital, London, United Kingdom.
ORCID-Profile: Rory McDonald, Reena Mehta, Marlies Ostermann
Förderung
- Medical Directorate
- European Society of Intensive Care Medicine
Zitieren
APA
McDonald, R., Watchorn, J., Mehta, R., Ostermann, M., & Hutchings, S. (2024). The REPERFUSE study protocol: The effects of vasopressor therapy on renal perfusion in patients with septic shock—A mechanistically focused randomised control trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0304227
Vancouver
McDonald R, Watchorn J, Mehta R, Ostermann M, Hutchings S. The REPERFUSE study protocol: The effects of vasopressor therapy on renal perfusion in patients with septic shock—A mechanistically focused randomised control trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0304227
BibTeX
@article{McDonald2024,
author = {McDonald, Rory and Watchorn, James and Mehta, Reena and Ostermann, Marlies and Hutchings, Sam},
title = {The REPERFUSE study protocol: The effects of vasopressor therapy on renal perfusion in patients with septic shock—A mechanistically focused randomised control trial},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304227}
}
EUVIMED